Skip to content

Clinical and Microbial Effect of Probiotics Combined with Periodontal Basic Treatment on Periodontitis: a Double-Blind Randomized Controlled Trial

Clinical and Microbial Effect of Probiotics Combined with Periodontal Basic Treatment on Periodontitis: a Double-Blind Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045040
Enrollment
Unknown
Registered
2021-04-03
Start date
2021-04-15
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Stage III

Interventions

Probiotics group:Periodontal basic treatment + probiotic lozenges
Placebo group:Periodontal basic treatment + placebo lozenges

Sponsors

Peking University School and Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged 35-60 years; 2.Patients with stage III localized or extensive periodontitis (New classification criteria for periodontal disease in 2018): CAL heaviest point on adjacent surface >= 5mm, radiographic bone loss was 1/3 or more of the root, with = 6mm, vertical bone absorption was >= 3mm, the root forking lesion was II or III degree, and the alveolar ridge defect was moderate. When the percentage of affected teeth conforming to the heaviest stage was = 30% was extensive type. 3.At least 2 affected teeth in each quadrant PPD >= 5mm, CAL >= 4mm; 4.Remaining teeth >= 20 (excluding teeth to be extracted), a minimum of 5 natural teeth in each quadrant, excluding third molars; 5.Overall health.

Exclusion criteria

Exclusion criteria: 1.Pregnancy and nursing women; 2.Having received periodontal treatment in the past 6 months; 3.Having received antibiotics for any purpose within 3 months prior to entering the study; prophylactic use of antibiotics needed before periodontal therapy; 4.Use of medication which may affect periodontal tissue, such as non-steroidal anti-inflammatory drugs; 5.Smoke; 6.Wearing a fixed orthodontic appliances; 7.Caries and bad restorations at the sampling sites; 8.Cardiovascular disease, lung disease, liver disease, immune system disease or diabetes; 9.Lactose or yogurt allergy.

Design outcomes

Primary

MeasureTime frame
Probing pocket depth;

Secondary

MeasureTime frame
Gingival recession;Clinical attachment loss;Bleeding on probing;Bleeding index;Plaque index;

Countries

China

Contacts

Public ContactOuyang Xiangying

Peking University School and Hospital of Stomatology

kqouyangxy@126.com+86 13621050102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026